Delivery Order SPE2DB22D2211-SPE2DB24FMNZ9
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ciproflox-Dexameth Otic Suspension 7.5ML, a pharmaceutical product, with a ceiling value of $5,379.73 and a completion date of September 19, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation. Amerisourcebergen Drug Corp is a major...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of pharmaceutical products, including the medication Ciproflox-Dexameth Otic Suspension. The contract has a ceiling value of $1,536.62 and an ultimate completion date of May 22, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Ciproflox-Dexameth Otic Suspension, a pharmaceutical product. The contract has a ceiling value of $1,105.36 and runs through June 13, 2023. This is a firm fixed-price delivery order contract, and there was no set-aside designation used. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order valued at $11,026.53 for the supply of Ciproflox-Dexameth Otic Suspension, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies,...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of Ciproflox-Dexameth Otic Suspension, a specialty pharmaceutical product, with a ceiling value of $1,002.60 and a period of performance through April 5, 2024. The award is structured as a firm fixed price delivery order and is not associated...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ciproflox-Dexameth Otic Suspension, a medical product, with a ceiling value of $1,644.90 and a period of performance through May 7, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,704.96, is for the delivery of Ciproflox-Dexameth Otic Suspension, a medical product used for various therapeutic purposes. The contract is a Delivery Order type with a Firm Fixed Price pricing structure. It does not have a set-aside designation, indicating open competition. Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $3,140.36, is for the delivery of Ciproflox-Dexameth Otic Suspension, a pharmaceutical product, with a performance period ending on July 26, 2022. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Ciprofloxacin-Dexamethasone Otic Suspension, a specialty pharmaceutical product, for a total ceiling value of $1,490.75. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,085.03 for the pharmaceutical product Ciproflox-Dexameth Otic Suspension (7.5 ml). The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FMNZ9Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of pharmaceutical products, including Ciproflox-Dexameth Otic Suspension, with a ceiling value of $4,945.82 and a completion date of January 11, 2024. The contract is a Delivery Order under a Firm Fixed Price contract type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 1/10/24 |